Sources

Construction of a trio-based structural variation panel utilizing activated T lymphocytes and long-read sequencing technology

Generated 2026-04-12 07:16 UTC

Metadata

title
Construction of a trio-based structural variation panel utilizing activated T lymphocytes and long-read sequencing technology
kind
paper
status
ingested
added
2026-04-07T09:46:12+09:00
raw source
raw/sources/otsuki_2022_construction_of_a_trio-based_structural.pdf
deep ingested
2026-04-07

Source

Study design

  • Samples: 333 individuals forming 111 trios
  • Platform: Oxford Nanopore long-read sequencing with mean depth around 22.2x and N50 around 25.8 kb
  • Aim: show that activated T lymphocytes can support scalable high-molecular-weight DNA prep and produce a validated population SV reference panel

Summary

  • The paper is as much about sample logistics as it is about variant discovery.
  • It argues that long-read population studies need a reliable source of high-quality DNA and proposes activated T lymphocytes as a practical biobank resource.
  • Using this setup, the study identifies 74,201 SVs and shows that more than 95% are concordant with Mendelian inheritance, producing a Japanese SV frequency panel.

Key findings

  • The study builds a population SV panel with trio-based inheritance checks rather than relying only on caller-internal quality scores.
  • Mean per-person discovery includes large numbers of deletions and insertions, supporting the claim that long-read WGS reveals substantially more SVs than short-read WGS.
  • Clinically relevant examples are highlighted for loci including hemoglobin genes, skin barrier genes, CYP2A6, and ATXN3.
  • The resulting panel is released through jMorp as JSV1, making it a usable downstream filtering resource rather than a closed paper-only dataset.

Strengths

  • Trio design provides unusually strong quality control for a population SV panel.
  • The paper addresses a real bottleneck in long-read population studies: DNA input quality at biobank scale.
  • It shows how long-read resources can become practical reference infrastructure, not just one-off discovery studies.

Limitations and caveats

  • The panel is ancestry-specific, so transferability outside Japanese cohorts is incomplete.
  • The study centers on SV discovery and allele frequencies, not full-spectrum clinical interpretation across all variant classes.
  • Activated T-cell workflows are operationally useful but may not be equally available across all biobanks.

Relevance to this corpus

  • This paper links long-read SV discovery to reference-panel building, which is crucial for rare disease filtering and population genetics.
  • It pairs naturally with the Han Chinese and 1,019-diverse-human studies as part of the corpus's population-atlas theme.

Open questions

  • How much depth is really required to build clinically useful SV frequency panels in new cohorts?
  • Can the activated T-cell DNA strategy be generalized across biobanks without introducing systematic biases?